
    
      1. Method

        1. This study was approved by the Institutional Review Board of the Wan Fang Medical Center
           at Taipei Medical University (WF99041, approved August 2010) and performed at the
           Reproductive Endocrinology Clinic at the Wan Fang Medical Center from 31 August 2010 to
           31 August 2011. The following women were excluded: (i) women who had been diagnosed with
           hyperprolactinemia, hypogonadotropic hypogonadism, premature ovarian failure, congenital
           adrenal hyperplasia, androgen-secreting tumor,Cushing's syndrome, disorders of the
           uterus and chromosomal anomalies; (ii) women who were less than three years past
           menarche or who were older than 45 years; (iii) women who received hormones or
           medication for major medical diseases (diabetes or cardiovascular disease); and (iv)
           women who had had ovarian cysts or ovarian tumors identified by ultrasonographic
           examination.

        2. Statistical analysis: We used chi-squared and Fisher's exact tests to perform
           categorical comparisons and ANOVA to compare the continuous variables. The means of more
           than two groups were compared using one-way ANOVA and post hoc Dunnett's t-test with
           equal variances not assumed.
    
  